Abstract
Background
Identifying drugs with circadian time-dependent efficacy (chronoefficacy) and understanding the underlying mechanisms would help to improve drug treatment outcome. Here, we aimed to determine chronoefficacy of the herbal medicines Puerariae radix (PR) and Coptidis rhizoma (CR), and investigate a potential role of REV-ERBα as a drug target in generating chronoefficacy.
Materials and methods
PR and CR efficacy were assessed based on the diseases hyperhomocysteinemia and chronic colitis, respectively. The efficacy of PR against hyperhomocysteinemia in mice was evaluated by measuring total homocysteine, triglyceride levels and lipid accumulation. The efficacy of CR against chronic colitis in mice was evaluated by measuring disease activity index, colon length, malondialdehyde/myeloperoxidase activities and IL-1β/IL-6 levels. The underlying mechanisms related to REV-ERBα target genes were analyzed by qPCR. Puerarin in PR and berberine in CR were analyzed by UPLC-QTOF/MS.
Results
PR dosed at ZT10 generated a better efficacy against hyperhomocysteinemia than drug dosed at ZT2. Furthermore, PR increased the expressions of REV-ERBα target genes Bhmt, Cbs and Cth (encoding three key enzymes responsible for homocysteine catabolism), thereby alleviating hyperhomocysteinemia in mice. Moreover, CR attenuated chronic colitis in mice in a circadian time-dependent manner. ZT10 dosing generated a better anti-colitis efficacy as compared to ZT2 dosing. This was accompanied by lower production of colonic inflammatory cytokines (i.e, Nlrp3, IL-1β, IL-6, Tnf-α and Ccl2, REV-ERBα target genes) in colitis mice at ZT10 dosing. The circadian patterns of PR and CR effects were respectively consistent with those of puerarin (a main active constituent of PR, a REV-ERBα antagonist) and berberine (a main active constituent of CR, a REV-ERBα agonist).
Conclusion
The therapeutic effects of PR and CR depend on dosing time in mice, which are probably attributed to circadian expression of REV-ERBα as the drug target. Our findings have implications for improving therapeutic outcomes of herbal medicines with a chronotherapeutics approach.